Literature DB >> 18458881

Lack of persistent effects of ketamine in rodent models of depression.

Piotr Popik1, Tomasz Kos, Magdalena Sowa-Kućma, Gabriel Nowak.   

Abstract

RATIONALE: We investigated the immediate and enduring effects of ketamine in behavioral and neurochemical assays predictive of antidepressant activity.
MATERIALS AND METHODS: One week after a single administration of ketamine (50-160 mg/kg), otherwise experimentally naive rats and mice were tested either in the forced swim test (FST) or the tail suspension test (TST). Other mice were also tested twice in the FST: immediately and 2 weeks after a single dose (1.25-50 mg/kg) of ketamine. In the next series of experiments, rats treated for 2 weeks twice daily with ketamine (50 or 160 mg/kg) or desipramine (10 mg/kg) were challenged with apomorphine and scored for locomotor activity and assayed for the density of cortical beta-adrenoceptors. The latter test was also carried out in rats that had received a single dose of ketamine (50 mg/kg) 1 week before the assay. The antidepressant-like (FST) and locomotor effects of ketamine (50 mg/kg) and desipramine (10 mg/kg) were assessed after their chronic (2 weeks, twice daily) administration as well.
RESULTS: We report the lack of enduring antidepressant-like effect of ketamine in both rats and mice. A 2-week treatment with ketamine neither changed apomorphine-evoked locomotor hyperactivity nor did it decrease the density of cortical beta-adrenoceptors. However, some tolerance to the antidepressant-like effect of ketamine was noted in the FST, but it was accompanied by sensitization to its locomotor stimulatory effects.
CONCLUSIONS: These data indicate that ketamine neither produces enduring antidepressant-like effects in rodents nor does it display antidepressant-like behavioral or neurochemical effects after chronic treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458881     DOI: 10.1007/s00213-008-1158-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  49 in total

1.  Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain.

Authors:  J Vetulani; F Sulser
Journal:  Nature       Date:  1975-10-09       Impact factor: 49.962

2.  Strain differences in changes in some parameters of cerebral cortical adrenergic system following chronic imipramine administration to rats.

Authors:  J Vetulani; I Nalepa; P Popik
Journal:  Pol J Pharmacol Pharm       Date:  1991 May-Jun

Review 3.  Psychiatric applications of bromocriptine therapy.

Authors:  P A Sitland-Marken; B G Wells; J H Froemming; C C Chu; C S Brown
Journal:  J Clin Psychiatry       Date:  1990-02       Impact factor: 4.384

4.  Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.

Authors:  K Ainsworth; S E Smith; T Sharp
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

5.  Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice.

Authors:  Tomasz Kos; Beata Legutko; Wojciech Danysz; Gary Samoriski; Piotr Popik
Journal:  J Pharmacol Exp Ther       Date:  2006-06-01       Impact factor: 4.030

6.  NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia.

Authors:  S Kapur; P Seeman
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

7.  Antidepressant-like effects of dopamine agonists in an animal model of depression.

Authors:  R Muscat; M Papp; P Willner
Journal:  Biol Psychiatry       Date:  1992-05-01       Impact factor: 13.382

8.  Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.

Authors:  B Lannes; G Micheletti; J M Warter; E Kempf; G Di Scala
Journal:  Neurosci Lett       Date:  1991-07-22       Impact factor: 3.046

9.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

10.  Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists.

Authors:  I A Paul; R Trullas; P Skolnick; G Nowak
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more
  28 in total

1.  CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy.

Authors:  Anita J Bechtholt-Gompf; Karen L Smith; Catherine S John; Hannah H Kang; William A Carlezon; Bruce M Cohen; Dost Ongür
Journal:  Psychopharmacology (Berl)       Date:  2011-01-28       Impact factor: 4.530

2.  Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors.

Authors:  Ramy E Abdelhamid; Katalin J Kovács; Myra G Nunez; Alice A Larson
Journal:  Pharmacol Res       Date:  2013-11-04       Impact factor: 7.658

3.  Enduring effects of adolescent ketamine exposure on cocaine- and sucrose-induced reward in male and female C57BL/6 mice.

Authors:  Israel Garcia-Carachure; Francisco J Flores-Ramirez; Samuel A Castillo; Anapaula Themann; Miguel A Arenivar; Joshua Preciado-Piña; Arturo R Zavala; Mary Kay Lobo; Sergio D Iñiguez
Journal:  Neuropsychopharmacology       Date:  2020-03-12       Impact factor: 7.853

Review 4.  Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Authors:  Gerard Sanacora; Giulia Treccani; Maurizio Popoli
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

5.  Ketamine induces immediate and delayed alterations of OCD-like behavior.

Authors:  Summer L Thompson; Amanda C Welch; Julia Iourinets; Stephanie C Dulawa
Journal:  Psychopharmacology (Berl)       Date:  2020-01-11       Impact factor: 4.530

6.  Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.

Authors:  Rachel J Donahue; John W Muschamp; Scott J Russo; Eric J Nestler; William A Carlezon
Journal:  Biol Psychiatry       Date:  2014-01-08       Impact factor: 13.382

7.  Locomotor sensitization to intermittent ketamine administration is associated with nucleus accumbens plasticity in male and female rats.

Authors:  C E Strong; K J Schoepfer; A M Dossat; S K Saland; K N Wright; M Kabbaj
Journal:  Neuropharmacology       Date:  2017-05-04       Impact factor: 5.250

8.  Ketamine Tolerance in Sprague-Dawley Rats after Chronic Administration of Ketamine, Morphine, or Cocaine.

Authors:  Samantha A Gerb; Jemma E Cook; Alexandria E Gochenauer; Camille S Young; Lindak K Fulton; Andrew W Grady; Kevin B Freeman
Journal:  Comp Med       Date:  2019-01-29       Impact factor: 0.982

9.  Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism.

Authors:  Valentina Gigliucci; Grainne O'Dowd; Sheena Casey; Danielle Egan; Sinead Gibney; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2013-03-02       Impact factor: 4.530

10.  Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice.

Authors:  Marika V Doucet; Hester Levine; Kumlesh K Dev; Andrew Harkin
Journal:  Neuropsychopharmacology       Date:  2013-02-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.